Breaking News, Collaborations & Alliances

Premier Research, BioCentriq Partner on Pre-IND Timelines

Aims to accelerate the clinical translation of novel cell therapy products.

Premier Research, a global clinical research, product development, and consulting company, and BioCentriq, a contract development and manufacturing organization (CDMO), have entered a strategic partnership to advance the pre-investigational New Drug (IND) process and accelerate the clinical translation of novel cell therapy products. By leveraging Premier Research’s expertise in cell therapy product development and regulatory expertise, with BioCentriq’s proficiency in developing,...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters